Combining Radiation with Hormonal Blockade for Prostate Cancer Disease

Posted on February 21, 2012 by

Question of the week:

Should I combine hormonal blockade with radiation

of the prostate?

These are the topics discussed on the program: 

1.  Who needs hormonal blockade in conjunction with

radiation of the prostate?

2.  What is the optimal time to start hormonal blockade

in conjunction with radiation of the prostate?

3.  What is the optimal time to stay on hormonal blockade

after radiation?

4.  What type of hormonal blockade should you use with

radiation of the prostate?

The related article of the week:

Androgenic suppression combined with radiotherapy

for the treatment of prostate adenocarcinoma:

A systematic review.  BMC Cancer 2012, 12:54 Ligia T Macedo

Posted in Ask Dr. Barken, Hormonal Blockade, Radiation Therapy, Radiation treatment, Treatments for Prostate Cancer | Tagged , , , , | Leave a comment

How does having a Medical Coach help in decision making?

Posted on February 14, 2012 by
Question of the week:  How does having a Medical
Coach help in decision making?  If you already
have a good medical team, will adding a Coach
make a difference?  
Dr. Barken answers the question and presents a video
commentary on his philosophy of Coaching, and how
he uses the Coaching Checklist to help patients.  
The following question is for the Ask Dr Barken
Call In Show on Tuesday, Feb. 14th at 6pm Pacific
Time.  Dial 1-877-727-3301 to hear the program.
Posted in Ask Dr. Barken, Checklist, Coaching, Decision Making, Markers, Treatments for Prostate Cancer | Tagged , , | Leave a comment

Question: Shall I do a biopsy of the prostate?

Posted on February 7, 2012 by

The following question is for the Ask Dr Barken

Call In Show on Tuesday, Feb. 7th at 6pm Pacific

Time.  Dial 1-877-727-3301 to hear the program.

Question of the week:  

An email from a patient gave brief medical history

and ended with this question, “Should I do a biopsy?”

 

Article:

Optimizing Repeat Prostate Biopsy Decisions and

Procedures.  BJU Int 2011 Dec 22.  Kirby R. 

The Prostate Centre, London, UK Mater Misericordiae

Hospital and University College Dublin, Dublin, Ireland

 

Dr. Barken answers the question and presents a video

commentary on Tues. Feb. 7th about whether to biopsy

or not, and what specifics to factor in when facing that

decision. He covers initial biopsy, repeat biopsy and

biopsy during Active Surveillance.

Posted in Active Surveillance, Ask Dr. Barken, Biopsy, Color Doppler Trans-Rectal Ultrasound, Decision Making, Diagnosis, Imaging, Markers, Prostate Cancer, PSA, Treatments for Prostate Cancer | Leave a comment

If the surgical margins are positive for PC, then what?

Posted on February 2, 2012 by

If the surgical margins are positive for PC, then what?

The following question is for the Ask Dr Barken

Call In Show on Tuesday, Jan 31st at 6PM pacific time. Dial 1-877-727-3301 to hear the rogram.

Question of the week:

What is the significance of positive surgical margins?

How should I deal with this situation?

Article:

Radical prostatectomy: Positive surgical margins matter.

Urologic Oncology: Seminars and Original Investigations.

J. J. Meeks, M.D., Ph.D., J.A. Eastham, M.D. , Dec. 2011

Urology Service, Department of Surgery, Memorial Sloan-

Kettering Cancer Center, New York, NY 10021

Dr. Barken answers the question and presents a video

commentary about positive surgical margins.

Posted in Treatments for Prostate Cancer | Leave a comment

If the surgical margins are positive for PC, then what?

Posted on January 31, 2012 by

If the surgical margins are positive for PC, then what?

The following question is for the Ask Dr Barken

Call In Show on Tuesday, Jan 31st at 6PM pacific time.  Dial 1-877-727-3301 to hear the rogram.

Question of the week:

What is the significance of positive surgical margins?

How should I deal with this situation?

Article:

Radical prostatectomy: Positive surgical margins matter.

Urologic Oncology: Seminars and Original Investigations.

J. J. Meeks, M.D., Ph.D., J.A. Eastham, M.D. , Dec. 2011

Urology Service, Department of Surgery, Memorial Sloan-

Kettering Cancer Center, New York, NY 10021

Dr. Barken answers the question and presents a video

commentary about positive surgical margins.

Posted in Journal Club, Prostate Cancer, Radical Prostatectomy, Treatments for Prostate Cancer | Tagged , , | Leave a comment

Ask Dr. Barken – C-Reactive Protein

Posted on January 23, 2012 by

The following question is for the Ask Dr Barken

Call In Show on Tuesday, Jan. 24th at 6pm Pacific

Time.  Dial 1-877-727-3301 to hear the program.

Question of the week:  

What is C-Reactive Protein?  When should you use

it as a marker?

Article:

C-reactive protein as an adverse prognostic marker

for men with castration-resistant prostate cancer (CRPC):

Confirmatory results. Urologic Oncology: Seminars

and Original Investigations 30 (2012) 33–37

Posted in Ask Dr. Barken, Diagnosis, Markers, Prognosis, Prostate Cancer, Survival prostate cancer, Treatments for Prostate Cancer | Tagged | Leave a comment

New Drugs in the Pipeline for Prostate Cancer

Posted on January 16, 2012 by
The following question is for the Ask Dr Barken
Call In Show on Tuesday, Jan. 17th at 6pm Pacific
Time.  Dial 1-877-727-3301 to hear the program.
Question of the week:  
What is the difference between hormone-insensitive,
hormone-refractory, hormone-independent and
castration-resistant prostate cancer?
 
Dr. Barken answers this question and introduces
a video  lecture about the subject.
Video Lecture:
Charles Drake, M.D. of Johns Hopkins discusses new
drugs in the pipeline for prostate cancer.  This presentation
took place at the annual Prostate Cancer Research Institute
public conference 2011.
Article:
MDV3100 for the treatment of prostate cancer. 
De-Bono JS.,  Expert Opin Investig Drugs. 2012 Jan 10
Posted in Immune Therapy, Metastatic Disease, Metastatic Prostate Cancer Disease, Prostate Cancer, Testosterone, Treatments for Prostate Cancer | Leave a comment